Doctor breaks down study showing GLP-1s may lower breast cancer risk
A new study published in JCO Oncology Practice suggests that GLP-1 weight-loss medications may reduce the risk of breast cancer in overweight or obese women by approximately 30%. Medical experts attribute this potential benefit to the drugs' ability to reduce inflammation, insulin levels, and estrogen production.
Why it matters
This research could significantly impact clinical guidelines for obesity management and cancer prevention strategies.
Good Morning America ShopGMA Interest Successfully Added We ll notify you here with news about Turn on desktop notifications for breaking stories about interest? Off On Stream on Wellness Doctor breaks down study showing GLP-1s may lower breast cancer risk 2:20 New study examines GLP-1 drugs and breast cancer risk Indranil Mukherjee/AFP via Getty Images By Dr. Chelsea Benmessaoud and Mason Leib June 3, 2026, 3:24 PM ABC News chief medical correspondent Dr. Tara Narula joined "Good Morning America" on Wednesday to discuss a new study that suggests GLP-1 medications may be linked to a reduced risk of developing breast cancer .
The article summarizes scientific findings and includes expert medical commentary without bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in